Little is known about the epidemiology of Toxoplasma gondii and Neospora caninum infections in alpacas (Vicugna pacos) and llamas (Lama glama) outside South America. The study aimed to estimate the seroprevalence of T. gondii and N. caninum infections in South American camelids (SAC) in Switzerland, to optimize serological tests for SAC and to identify risk factors, which may favour infection.
METHODS
A total of 571 sera from 132 Swiss farms (374 alpacas and 197 llamas, mean 4.3 animals/farm) were obtained. Four commercial enzyme-linked immunosorbent assays (ELISA) for detecting antibodies against T. gondii (ID Screen® Toxoplasmosis Indirect (TOXO-MS)) or N. caninum (i.e. ID Screen® Neospora caninum Indirect Multi-species (NCS-MS); ID Screen® Neospora caninum Competition (NCC) and ID Screen® Neospora caninum Indirect (NCS)) were first assessed for their use on SAC comparing their results with those in immunoblot, and optimizing cut-offs. Subsequently, two kits (TOXO-MS and NCS-MS) were selected for seroprevalence estimation. Additionally, a risk factor analysis for infection was performed on 41 farms, which agreed to participate in a web-based survey.
NLG919 |
A4373-50 |
ApexBio |
50 mg |
EUR 588 |
Description: NLG919 is a novel and orally-bioavailable small-molecule inhibitor of indoleamine 2,3-dioxygenase (IDO) pathway, a crucial pathway involved in allergic inflammation that mediates immunosuppressive effects through metabolization of tryptophan (Trp) to kynurenine. |
NLg919 |
20-abx182602 |
Abbexa |
-
EUR 878.40
-
EUR 727.20
-
EUR 2030.40
|
|
|
Indoximod (NLG-8189) |
B4900-200 |
ApexBio |
200 mg |
EUR 250.8 |
Description: Indoximod is an Indoleamine 2,3-dioxygenase (IDO) pathway inhibitor. IDO is a tryptophan-catabolizing enzyme that tumors use to create a state of immunosuppression. |
Indoximod (NLG-8189) |
B4900-50 |
ApexBio |
50 mg |
EUR 153.6 |
Description: Indoximod is an Indoleamine 2,3-dioxygenase (IDO) pathway inhibitor. IDO is a tryptophan-catabolizing enzyme that tumors use to create a state of immunosuppression. |
Rabbit Anti-Human Filtrin/NLG1 IgG #1, aff pure |
NLG11-A |
Alpha Diagnostics |
100 ug |
EUR 578.4 |
Human Filtrin/NLG1 Control/blocking peptide #1 |
NLG11-P |
Alpha Diagnostics |
100 ug |
EUR 196.8 |
Recombinant Caenorhabditis Elegans nlg-1 Protein (aa 18-798) |
VAng-Ly3572-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Caenorhabditis Elegans neuroligin-1 (nlg-1), partial, recombination protein. |
NLGN1 siRNA |
20-abx925994 |
Abbexa |
|
|
|
NLGN1 siRNA |
20-abx925995 |
Abbexa |
|
|
|
NLGN2 siRNA |
20-abx925996 |
Abbexa |
|
|
|
NLGN2 siRNA |
20-abx925997 |
Abbexa |
|
|
|
NLGN3 siRNA |
20-abx925998 |
Abbexa |
|
|
|
NLGN3 siRNA |
20-abx925999 |
Abbexa |
|
|
|
NLGN1 siRNA |
20-abx903571 |
Abbexa |
|
|
|
NLGN2 siRNA |
20-abx903572 |
Abbexa |
|
|
|
NLGN3 siRNA |
20-abx903573 |
Abbexa |
|
|
|
NLGN4X siRNA |
20-abx926000 |
Abbexa |
|
|
|
NLGN4Y siRNA |
20-abx926001 |
Abbexa |
|
|
|
NLGN1 Rabbit pAb |
A16105-100ul |
Abclonal |
100 ul |
EUR 369.6 |
NLGN1 Rabbit pAb |
A16105-200ul |
Abclonal |
200 ul |
EUR 550.8 |
NLGN1 Rabbit pAb |
A16105-20ul |
Abclonal |
20 ul |
EUR 219.6 |
NLGN1 Rabbit pAb |
A16105-50ul |
Abclonal |
50 ul |
EUR 267.6 |
NLGN3 Rabbit pAb |
A10310-100ul |
Abclonal |
100 ul |
EUR 369.6 |
NLGN3 Rabbit pAb |
A10310-200ul |
Abclonal |
200 ul |
EUR 550.8 |
NLGN3 Rabbit pAb |
A10310-20ul |
Abclonal |
20 ul |
EUR 219.6 |
NLGN3 Rabbit pAb |
A10310-50ul |
Abclonal |
50 ul |
EUR 267.6 |
NLGN2 Rabbit pAb |
A14289-100ul |
Abclonal |
100 ul |
EUR 369.6 |
NLGN2 Rabbit pAb |
A14289-200ul |
Abclonal |
200 ul |
EUR 550.8 |
NLGN2 Rabbit pAb |
A14289-20ul |
Abclonal |
20 ul |
EUR 219.6 |
NLGN2 Rabbit pAb |
A14289-50ul |
Abclonal |
50 ul |
EUR 267.6 |
NLGN2 Rabbit pAb |
A14418-100ul |
Abclonal |
100 ul |
EUR 369.6 |
NLGN2 Rabbit pAb |
A14418-200ul |
Abclonal |
200 ul |
EUR 550.8 |
NLGN2 Rabbit pAb |
A14418-20ul |
Abclonal |
20 ul |
EUR 219.6 |
NLGN2 Rabbit pAb |
A14418-50ul |
Abclonal |
50 ul |
EUR 267.6 |
NLGN2 Peptide |
7969P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (NT) NLGN2 Peptide |
NLGN4X Peptide |
43-069P |
ProSci |
0.1 mg |
EUR 405.6 |
Description: NLGN4X Peptide |
NLGN3 Antibody |
46087-100ul |
SAB |
100ul |
EUR 302.4 |
NLGN3 Antibody |
46087-50ul |
SAB |
50ul |
EUR 224.4 |
NLGN1 Antibody |
46627-100ul |
SAB |
100ul |
EUR 302.4 |
NLGN4Y Rabbit pAb |
A4513-100ul |
Abclonal |
100 ul |
EUR 369.6 |
NLGN4Y Rabbit pAb |
A4513-200ul |
Abclonal |
200 ul |
EUR 550.8 |
NLGN4Y Rabbit pAb |
A4513-20ul |
Abclonal |
20 ul |
EUR 219.6 |
NLGN4Y Rabbit pAb |
A4513-50ul |
Abclonal |
50 ul |
EUR 267.6 |
NLGN2 Antibody |
7969-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
Description: Neuroligin 2 (NLGN2) is a member of a family of neuronal cell surface proteins that localize to the post-synaptic membrane (1,2). Neuroligins are thought to act as splice site-specific ligands for beta-neurexins and may be involved in the formation and remodeling of central nervous system synapses (2). NLGN2 has been shown to control perisomatic inhibitory synapse maturation together with gephyrin and collybistin, thereby regulating GABA receptor clustering on neurons (3,4). NLGN2 also exhibits differential functions at different types of inhibitory synapses on the same postsynaptic neuron (5). |
NLGN2 Antibody |
7969-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
Description: Neuroligin 2 (NLGN2) is a member of a family of neuronal cell surface proteins that localize to the post-synaptic membrane (1,2). Neuroligins are thought to act as splice site-specific ligands for beta-neurexins and may be involved in the formation and remodeling of central nervous system synapses (2). NLGN2 has been shown to control perisomatic inhibitory synapse maturation together with gephyrin and collybistin, thereby regulating GABA receptor clustering on neurons (3,4). NLGN2 also exhibits differential functions at different types of inhibitory synapses on the same postsynaptic neuron (5). |
NLGN4X Rabbit pAb |
A7986-100ul |
Abclonal |
100 ul |
EUR 369.6 |
NLGN4X Rabbit pAb |
A7986-200ul |
Abclonal |
200 ul |
EUR 550.8 |
NLGN4X Rabbit pAb |
A7986-20ul |
Abclonal |
20 ul |
EUR 219.6 |
NLGN4X Rabbit pAb |
A7986-50ul |
Abclonal |
50 ul |
EUR 267.6 |
NLGN1 Antibody |
36650-100ul |
SAB |
100ul |
EUR 302.4 |
NLGN2 Antibody |
39957-100ul |
SAB |
100ul |
EUR 468 |
NLGN1 Antibody |
1-CSB-PA839786LA01HU |
Cusabio |
|
|
|
Description: A polyclonal antibody against NLGN1. Recognizes NLGN1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC, IF; Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200 |
NLGN1 Antibody |
1-CSB-PA928711 |
Cusabio |
|
|
|
Description: A polyclonal antibody against NLGN1. Recognizes NLGN1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:50-1:200 |
NLGN3 Antibody |
1-CSB-PA873703LA01HU |
Cusabio |
|
|
|
Description: A polyclonal antibody against NLGN3. Recognizes NLGN3 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IF; Recommended dilution: IF:1:200-1:500 |
NLGN4Y antibody |
70R-18894 |
Fitzgerald |
50 ul |
EUR 522 |
Description: Rabbit polyclonal NLGN4Y antibody |
NLGN4X antibody |
70R-6162 |
Fitzgerald |
50 ug |
EUR 560.4 |
Description: Rabbit polyclonal NLGN4X antibody raised against the N terminal of NLGN4X |
NLGN4X antibody |
70R-6163 |
Fitzgerald |
50 ug |
EUR 560.4 |
Description: Rabbit polyclonal NLGN4X antibody raised against the middle region of NLGN4X |
NLGN4Y Antibody |
1-CSB-PA015858GA01HU |
Cusabio |
|
|
|
Description: A polyclonal antibody against NLGN4Y. Recognizes NLGN4Y from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB |
NLGN4X Antibody |
1-CSB-PA843131LA01HU |
Cusabio |
|
|
|
Description: A polyclonal antibody against NLGN4X. Recognizes NLGN4X from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IF; Recommended dilution: IF:1:200-1:500 |
NLGN4Y Antibody |
1-CSB-PA818786ESR1HU |
Cusabio |
|
|
|
Description: A polyclonal antibody against NLGN4Y. Recognizes NLGN4Y from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC; Recommended dilution: WB:1:500-1:2000, IHC:1:20-1:200 |
NLGN4X Antibody |
R34949-100UG |
NSJ Bioreagents |
100 ug |
EUR 339.15 |
Description: Additional name(s) for this target protein: Neuroligin 4 X-linked |
anti-NLGN1 + NLGN2 |
YF-PA25805 |
Abfrontier |
50 ul |
EUR 400.8 |
Description: Mouse polyclonal to NLGN1 + NLGN2 |
anti-NLGN1 + NLGN2 |
YF-PA17644 |
Abfrontier |
50 ug |
EUR 435.6 |
Description: Mouse polyclonal to NLGN1 + NLGN2 |
Nlgn1 ORF Vector (Rat) (pORF) |
ORF071349 |
ABM |
1.0 ug DNA |
EUR 607.2 |
Nlgn2 ORF Vector (Rat) (pORF) |
ORF071350 |
ABM |
1.0 ug DNA |
EUR 607.2 |
Nlgn3 ORF Vector (Rat) (pORF) |
ORF071351 |
ABM |
1.0 ug DNA |
EUR 607.2 |
Anti-NLGN1 + NLGN2 (2G7) |
YF-MA17750 |
Abfrontier |
100 ug |
EUR 435.6 |
Description: Mouse monoclonal to NLGN1 + NLGN2 |
Anti-NLGN1 + NLGN2 (1D6) |
YF-MA17751 |
Abfrontier |
100 ug |
EUR 435.6 |
Description: Mouse monoclonal to NLGN1 + NLGN2 |
Rat NLGN1 shRNA Plasmid |
20-abx987310 |
Abbexa |
|
|
|
Rat NLGN2 shRNA Plasmid |
20-abx987407 |
Abbexa |
|
|
|
Rat NLGN3 shRNA Plasmid |
20-abx987731 |
Abbexa |
|
|
|
anti- NLGN4Y antibody |
FNab05755 |
FN Test |
100µg |
EUR 702 |
|
Description: Antibody raised against NLGN4Y |
NLGN3 cloning plasmid |
CSB-CL873703HU-10ug |
Cusabio |
10ug |
EUR 966 |
|
Description: A cloning plasmid for the NLGN3 gene. |
NLGN1 cloning plasmid |
CSB-CL839786HU-10ug |
Cusabio |
10ug |
EUR 568.8 |
|
Description: A cloning plasmid for the NLGN1 gene. |
NLGN1 ORF Vector (Human) (pORF) |
ORF007100 |
ABM |
1.0 ug DNA |
EUR 114 |
NLGN3 ORF Vector (Human) (pORF) |
ORF007101 |
ABM |
1.0 ug DNA |
EUR 114 |
NLGN2 ORF Vector (Human) (pORF) |
ORF026133 |
ABM |
1.0 ug DNA |
Ask for price |
Nlgn1 ORF Vector (Mouse) (pORF) |
ORF051429 |
ABM |
1.0 ug DNA |
EUR 607.2 |
Nlgn1 ORF Vector (Mouse) (pORF) |
ORF051430 |
ABM |
1.0 ug DNA |
EUR 607.2 |
Nlgn2 ORF Vector (Mouse) (pORF) |
ORF051431 |
ABM |
1.0 ug DNA |
EUR 607.2 |
Nlgn3 ORF Vector (Mouse) (pORF) |
ORF051432 |
ABM |
1.0 ug DNA |
EUR 607.2 |
NLGN1 3'UTR GFP Stable Cell Line |
TU065735 |
ABM |
1.0 ml |
EUR 5540.4 |
NLGN2 3'UTR GFP Stable Cell Line |
TU065736 |
ABM |
1.0 ml |
EUR 1825.2 |
NLGN3 3'UTR GFP Stable Cell Line |
TU065737 |
ABM |
1.0 ml |
EUR 1672.8 |
Nlgn1 3'UTR GFP Stable Cell Line |
TU264018 |
ABM |
1.0 ml |
Ask for price |
Nlgn2 3'UTR GFP Stable Cell Line |
TU264019 |
ABM |
1.0 ml |
Ask for price |
Nlgn3 3'UTR GFP Stable Cell Line |
TU264020 |
ABM |
1.0 ml |
Ask for price |
Nlgn1 3'UTR GFP Stable Cell Line |
TU164133 |
ABM |
1.0 ml |
Ask for price |
Nlgn2 3'UTR GFP Stable Cell Line |
TU164134 |
ABM |
1.0 ml |
Ask for price |
Nlgn3 3'UTR GFP Stable Cell Line |
TU164135 |
ABM |
1.0 ml |
Ask for price |
Mouse NLGN3 shRNA Plasmid |
20-abx982762 |
Abbexa |
|
|
|
Human NLGN1 shRNA Plasmid |
20-abx957828 |
Abbexa |
|
|
|
Human NLGN3 shRNA Plasmid |
20-abx960047 |
Abbexa |
|
|
|
NLGN4Y cloning plasmid |
CSB-CL818786HU1-10ug |
Cusabio |
10ug |
EUR 279.6 |
|
Description: A cloning plasmid for the NLGN4Y gene. |
NLGN4Y cloning plasmid |
CSB-CL818786HU2-10ug |
Cusabio |
10ug |
EUR 955.2 |
|
Description: A cloning plasmid for the NLGN4Y gene. |
Human NLGN2 shRNA Plasmid |
20-abx961532 |
Abbexa |
|
|
|
Mouse NLGN1 shRNA Plasmid |
20-abx980407 |
Abbexa |
|
|
|
Mouse NLGN2 shRNA Plasmid |
20-abx981044 |
Abbexa |
|
|
|
NLGN1 Blocking Peptide |
DF9690-BP |
Affbiotech |
1mg |
EUR 234 |
NLGN2 Blocking Peptide |
DF9691-BP |
Affbiotech |
1mg |
EUR 234 |
NLGN3 Blocking Peptide |
DF9692-BP |
Affbiotech |
1mg |
EUR 234 |
NLGN4X cloning plasmid |
CSB-CL843131HU-10ug |
Cusabio |
10ug |
EUR 568.8 |
|
Description: A cloning plasmid for the NLGN4X gene. |
NLGN4Y ORF Vector (Human) (pORF) |
ORF013890 |
ABM |
1.0 ug DNA |
EUR 424.8 |
NLGN4X ORF Vector (Human) (pORF) |
ORF007102 |
ABM |
1.0 ug DNA |
EUR 114 |
NLGN4Y ORF Vector (Human) (pORF) |
ORF007103 |
ABM |
1.0 ug DNA |
EUR 114 |
NLGN4X 3'UTR GFP Stable Cell Line |
TU065738 |
ABM |
1.0 ml |
EUR 1825.2 |
NLGN4Y 3'UTR GFP Stable Cell Line |
TU065739 |
ABM |
1.0 ml |
EUR 2799.6 |
Human NLGN4Y shRNA Plasmid |
20-abx957796 |
Abbexa |
|
|
|
NLGN4X Blocking Peptide |
33R-2543 |
Fitzgerald |
100 ug |
EUR 216 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of NLGN4X antibody, catalog no. 70R-6163 |
NLGN4X Blocking Peptide |
33R-8532 |
Fitzgerald |
100 ug |
EUR 216 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of NLGN4X antibody, catalog no. 70R-6162 |
Human NLGN4X shRNA Plasmid |
20-abx961488 |
Abbexa |
|
|
|
Rat Neuroligin 1 (NLGN1) ELISA Kit |
DLR-NLGN1-Ra-48T |
DL Develop |
48T |
EUR 658.8 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Rat Neuroligin 1 (NLGN1) in samples from serum, plasma, tissue homogenates or other biological fluids. |
Rat Neuroligin 1 (NLGN1) ELISA Kit |
DLR-NLGN1-Ra-96T |
DL Develop |
96T |
EUR 861.6 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Rat Neuroligin 1 (NLGN1) in samples from serum, plasma, tissue homogenates or other biological fluids. |
Rat Neuroligin 1 (NLGN1) ELISA Kit |
abx576772-96tests |
Abbexa |
96 tests |
EUR 1074 |
|
NLGN1-AS1 ORF Vector (Human) (pORF) |
ORF026132 |
ABM |
1.0 ug DNA |
Ask for price |
Rat Neuroligin 1 (NLGN1) ELISA Kit |
RD-NLGN1-Ra-48Tests |
Reddot Biotech |
48 Tests |
EUR 668.4 |
Rat Neuroligin 1 (NLGN1) ELISA Kit |
RD-NLGN1-Ra-96Tests |
Reddot Biotech |
96 Tests |
EUR 930 |
Rat Neuroligin 1 (NLGN1) ELISA Kit |
RDR-NLGN1-Ra-48Tests |
Reddot Biotech |
48 Tests |
EUR 699.6 |
Rat Neuroligin 1 (NLGN1) ELISA Kit |
RDR-NLGN1-Ra-96Tests |
Reddot Biotech |
96 Tests |
EUR 973.2 |
NLGN4YAS 3'UTR GFP Stable Cell Line |
TU065740 |
ABM |
1.0 ml |
EUR 2799.6 |
Rat Neuroligin 1 (NLGN1) ELISA Kit |
RD-NLGN1-Ra-48T |
Reddot Biotech |
48T |
EUR 487.7 |
|
Description: serum, plasma, tissue homogenates and other biological fluids. |
Rat Neuroligin 1 (NLGN1) ELISA Kit |
RD-NLGN1-Ra-96T |
Reddot Biotech |
96T |
EUR 696.7 |
|
Description: serum, plasma, tissue homogenates and other biological fluids. |
Rat Neuroligin 1 (NLGN1) ELISA Kit |
RDR-NLGN1-Ra-48T |
Reddot Biotech |
48T |
EUR 512.09 |
|
Description: serum, plasma, tissue homogenates and other biological fluids. |
Rat Neuroligin 1 (NLGN1) ELISA Kit |
RDR-NLGN1-Ra-96T |
Reddot Biotech |
96T |
EUR 731.54 |
|
Description: serum, plasma, tissue homogenates and other biological fluids. |
NLGN2 Polyclonal Antibody |
28485-100ul |
SAB |
100ul |
EUR 302.4 |
NLGN2 Polyclonal Antibody |
28485-50ul |
SAB |
50ul |
EUR 224.4 |
NLGN2 Polyclonal Antibody |
28559-100ul |
SAB |
100ul |
EUR 302.4 |
NLGN2 Polyclonal Antibody |
28559-50ul |
SAB |
50ul |
EUR 224.4 |
Polyclonal NLGN2 Antibody |
AMM06711G |
Leading Biology |
0.1 mg |
EUR 790.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NLGN2 . This antibody is tested and proven to work in the following applications: |
NLGN1 Polyclonal Antibody |
ABP59477-003ml |
Abbkine |
0.03ml |
EUR 189.6 |
|
Description: A polyclonal antibody for detection of NLGN1 from Human, Mouse, Rat. This NLGN1 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human NLGN1 protein at amino acid sequence of 410-490 |
NLGN1 Polyclonal Antibody |
ABP59477-01ml |
Abbkine |
0.1ml |
EUR 346.8 |
|
Description: A polyclonal antibody for detection of NLGN1 from Human, Mouse, Rat. This NLGN1 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human NLGN1 protein at amino acid sequence of 410-490 |
NLGN1 Polyclonal Antibody |
ABP59477-02ml |
Abbkine |
0.2ml |
EUR 496.8 |
|
Description: A polyclonal antibody for detection of NLGN1 from Human, Mouse, Rat. This NLGN1 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human NLGN1 protein at amino acid sequence of 410-490 |
NLGN2 Polyclonal Antibody |
ABP59478-003ml |
Abbkine |
0.03ml |
EUR 189.6 |
|
Description: A polyclonal antibody for detection of NLGN2 from Human, Mouse, Rat. This NLGN2 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human NLGN2 protein at amino acid sequence of 310-390 |
NLGN2 Polyclonal Antibody |
ABP59478-01ml |
Abbkine |
0.1ml |
EUR 346.8 |
|
Description: A polyclonal antibody for detection of NLGN2 from Human, Mouse, Rat. This NLGN2 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human NLGN2 protein at amino acid sequence of 310-390 |
NLGN2 Polyclonal Antibody |
ABP59478-02ml |
Abbkine |
0.2ml |
EUR 496.8 |
|
Description: A polyclonal antibody for detection of NLGN2 from Human, Mouse, Rat. This NLGN2 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human NLGN2 protein at amino acid sequence of 310-390 |
NLGN3 Polyclonal Antibody |
ABP59479-003ml |
Abbkine |
0.03ml |
EUR 189.6 |
|
Description: A polyclonal antibody for detection of NLGN3 from Human, Mouse, Rat. This NLGN3 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human NLGN3 protein at amino acid sequence of 610-690 |
NLGN3 Polyclonal Antibody |
ABP59479-01ml |
Abbkine |
0.1ml |
EUR 346.8 |
|
Description: A polyclonal antibody for detection of NLGN3 from Human, Mouse, Rat. This NLGN3 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human NLGN3 protein at amino acid sequence of 610-690 |
NLGN3 Polyclonal Antibody |
ABP59479-02ml |
Abbkine |
0.2ml |
EUR 496.8 |
|
Description: A polyclonal antibody for detection of NLGN3 from Human, Mouse, Rat. This NLGN3 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human NLGN3 protein at amino acid sequence of 610-690 |
Rat Neuroligin-3 (NLGN3) ELISA Kit |
abx515747-96tests |
Abbexa |
96 tests |
EUR 801.6 |
|
Three kits (TOXO-MS, NCS-MS and NCC) showed almost perfect agreement (kappa > 0.901) with immunoblot results when the cut-offs were optimized, and one kit (NCS) proved not to be useful for detecting N. caninum seropositive SAC. By TOXO-MS ELISA, 82.3% (308/374) of the alpacas and 84.8% (167/197) of the llamas were seropositive for T. gondii, and 131/132 (99.2%) farms had seropositive animals. By NCS-MS ELISA, 3.5% (13/374) of the alpacas and 2.5% (5/197) of the llamas evidenced antibodies against N. caninum, and 9.1% (12/132) of the farms had seropositive animals.
The variables “age” and “female sex” were identified as risk factors for T. gondii infection and “absence of cats in the farm during the last two years” as a protective factor. No risk or protective factors for N. caninum infection could be identified.This nationwide cross-sectional study demonstrated for the first time the presence of antibodies against T. gondii and N. caninum in the Swiss SAC population, highlighting a high seroprevalence for T. gondii, the presence of cats as a risk factor and suggesting that SAC meat might represent an additional infection source for humans.